6533b85bfe1ef96bd12bad41

RESEARCH PRODUCT

IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system.

Shinji YamashitaPeter LangguthPhilipp BuchMakoto Kataoka

subject

MaleChemistry PharmaceuticalPharmaceutical ScienceAdministration OralAbsorption (skin)PharmacologyDosage formPermeabilityAbsorptionIVIVCPharmacokineticsFenofibrateIn vivoOral administrationmedicineAnimalsHumansRats WistarHypolipidemic AgentsFenofibrateChemistryPermeationRatsSolubilityCaco-2 Cellsmedicine.drugTablets

description

ABSTRACT: The usefulness of a dissolution/permeation (D/P) system to predict the in vivo performance of solid dosage forms containing the poorly soluble drug, fenofibrate, was studied. Biorelevant dissolution media simulating the fasted and fed state conditions of the human gastrointestinal tract were used in order to simulate the effect of food on the absorption of fenofibrate. Moreover, the results obtained from the D/P system were correlated with pharmacokinetic parameters obtained following in vivo studies in rats. The in vitro parameter (amount permeated in the D/P system) reflected well the in vivo performance in rats in terms of AUC and C max of fenofibric acid. This study thus demonstrates the potential of the D/P system as valuable tool for absorption screening of dosage forms for poorly soluble drugs. © 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:2001–2009, 2009

10.1002/jps.21576https://pubmed.ncbi.nlm.nih.gov/18855916